
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Japanese Miso Ferment contains bioactive peptides including diketopiperazines and pyroglutamyl peptides that inhibit angiotensin-converting enzyme (ACE), with l-β-Asp-Pro showing an IC₅₀ of 4.8 μM. The fermentation process generates antioxidant phenolic compounds and lipopolysaccharide-neutralizing proteins that support cardiovascular and digestive health.

Reported Benefits (Provisional)
Origin & History

Miso is a traditional Japanese fermented paste made by culturing soybeans (Glycine max) with salt and the mold Aspergillus oryzae, often blended with rice or barley. Aged for weeks to years, it yields a complex umami profile and is central to Japanese culinary and wellness traditions, revered for its probiotic content, digestive support, and rich nutritional benefits.
Research Narrative (Provisional)
Scientific research supports the role of probiotics in miso in promoting gut and immune health. Studies also highlight the cardiovascular and metabolic benefits of its isoflavone content, with fermentation enhancing antioxidant activity and bioavailability of key nutrients.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Probiotics: Contains beneficial bacteria like Lactobacillus and the mold Aspergillus oryzae, which support gut microbiota. - Plant Protein: Complete plant-based protein providing essential amino acids for cellular repair and metabolism. - Isoflavones: Soy-derived phytoestrogens that support cardiovascular and hormonal health. - Vitamins: Rich in B2 (riboflavin), B6, B12, and Vitamin K2 (menaquinone). - Minerals: Contains zinc, copper, manganese, and phosphorus, essential for metabolic and antioxidant support.
Reported Mechanism (Provisional)
Fermentation of Glycine max generates modified peptides including diketopiperazines, isomerized aspartyl peptides, and pyroglutamyl peptides that inhibit angiotensin-converting enzyme, reaching plasma concentrations of 10-400 nM within one hour of oral administration. The fermentation process also produces soluble phenolic compounds that reduce lipid peroxidation markers and lipopolysaccharide-neutralizing proteins that counteract intestinal bacterial endotoxins. N-acetyl and N-formyl amino acids, monoamines, and polyamines generated during koji fermentation contribute to enhanced bioavailability of bioactive compounds.
Clinical Narrative (Provisional)
Limited human clinical evidence exists, with one observational study showing habitual miso consumption associated with reduced sarcopenia risk in women (OR 0.20, 95% CI: 0.06-0.62, p=0.005). Animal studies demonstrate ACE inhibitory peptide bioavailability with 17 diketopiperazines and 16 isomerized aspartyl peptides detected in portal circulation one hour post-administration. Controlled animal trials show reduced lipid peroxidation markers in high-fat diet models, though human randomized controlled trial data remains sparse. Evidence is primarily derived from mechanistic studies and animal models rather than large-scale human clinical trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







